logo-loader
ASX:IMU

Imugene Ltd

 Receive alerts
Market:
ASX
Market Cap:
$75.81 m
Price
$0.02
Change
0.00%
52 weeks high
0.03
52 weeks low
0.01

In brief

Imugene Ltd (ASX:IMU) is listed on the Australian Securities Exchange.

In brief Latest news Insight Interviews

Latest news

Imugene to acquire exclusive licence for potentially transformational...

on 15/7/19

Imugene reveals new clinical data for HER-Vaxx vaccine showing...

on 8/7/19

Imugene presents new HER-Vaxx cancer vaccine results

on 4/6/19

Imugene appoints venture capital executive to board

on 20/5/19

Imugene to present new data from HER-Vaxx cancer vaccine phase 1b trial

on 29/4/19

Imugene appoints global pharmaceutical executive to its board

on 23/4/19

Imugene well-funded to progress clinical milestones

on 16/4/19

Imugene presents positive new data validating its human cancer vaccine KEY-Vaxx

on 3/4/19

Insight

A stomach adenocarcinoma Imugene targets defender B-cells with cancer vaccines HER-Vaxx and B-Vaxx
on 13/2/19

Interviews

1562553116_Imugene.jpg Health Imugene Limited releases new clinical data for HER-Vaxx cancer vaccine study
on 8/7/19
1553041367_IMU-thumb-2.jpg Health Imugene obtains FDA guidance for KEY-Vaxx immunotherapy clinical development plan
on 20/3/19
1552626645_IMU-thumb.jpg Health Imugene doses first patient in phase-two study of cancer vaccine
on 15/3/19
1551656014_imu2.jpg Health Imugene presenting all three immuno-oncology programs at AACR Annual Meeting
on 3/3/19
View all